Skip to Main Content

Paper Details

Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
Eur Urol
44
2021
Author NameAffiliation
Rachel M GlicksmanUniversity of Toronto, College Street
Robert G BristowManchester Cancer Research Centre, University of Manchester
Antonio FinelliUniversity Health Network, University of Toronto
Neil E FleshnerUniversity Health Network, University of Toronto
Alexandre R ZlottaUniversity Health Network, University of Toronto
Girish S KulkarniUniversity Health Network, University of Toronto
Alejandro BerlinUniversity of Toronto, College Street, Princess Margaret Cancer Centre, University Health Network, 700 University Avenue, Canada TECHNA Institute
  • 1 - 7

Datasets